Levonorgestrel Market Size, Share, and Industry Analysis, By Type (Levonorgestrel Table, Mixture Products, Hormone-releasing IUD), By Application (Hospital, Drug Store, Online Sale) Regional Forecast To 2028

Updated On: 13 March 2023

REPORT OVERVIEW

• 
• Request a Free sample to learn more about this report

The global levonorgestrel market size was USD 48 million in 2021. The global COVID-19 pandemic has been unprecedented and staggering, with levonorgestrel experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. As per our research, the market is projected to touch USD 60 million by 2028, exhibiting a CAGR of 3.3% during the projected period. The sudden spike in CAGR is attributable to demand returning to pre-pandemic levels once the pandemic is over.

Levonorgestrel (LNG) is indeed a synthesised progestogen that works similarly to progesterone and is employed in contraception and hormonal treatment.  It is also known as Plan B and is utilized as a single agent in extremity contraception along with a (preventive) hormonal contraceptive ejected through an intrauterine device or tool (IUD). Jaydess, Kyleena, as well as Mirena are some of these devices. There is also a levonorgestrel subdermal implant which gradually releases the hormone over time. In relation to the utilisation listed above, the pill is a part of long-term pairing contraceptives.

Levonorgestrel is the widely utilized case of emergencies contraceptive worldwide. It was the initial emergency contraceptive to be approved by the FDA in 1982, and so it demonstrated elevated amounts of effectiveness and an absence of estrogenic negative impacts when compared to previous emergency contraceptive regimens.

COVID-19 Impact: Supply and Lockdown Limitations to Impede Market Advancement

Coronavirus has had a negative impact on the growth of many businesses, including the activities and manufacturing of medicinal pills. Regional governments around the world levied shutdown, causing business owners to see a reduction in the demand for many births control medicines in the second and third quarters of 2020.

With the decrease in demand, manufacturers or industrialists have pursued out ways to reach the hospital and pharmacy sector and government concessions in order to increase their product sales in the third and fourth quarters of 2020. The reopening of initiatives has cleared the way for the drugs manufacturers in the market, and growing demand is anticipated to reach at greater levels during the estimated timeframe. Therefore, making the drug to reach at greater heights.

LATEST TRENDS 

"New Inventions and Advancements to Stimulate Market Development "

So far, these specialized pills for birth control have only been available to females. A recent study by the American Chemical Society, in contrast hand, revealed a good lead towards manufactured birth control pills. The invention is based on ouabain, an extract from a flower which African poachers and gunslingers used in the past to treat heart-stopping poison delivered via arrow. It has been discovered that ouabain can interfere with the transmission of sodium and calcium ions through the membrane protein. This is thought to be necessary for reproduction, and has been verified and tested on male mice. There had been no poisoning observed in the rats, and if the clinical trials go as planned, this introduction may open up significant new opportunities for the global emergence levonorgestrel market growth.

The levonorgestrel market growth is expected to grow at a rapid rate throughout the forecast period because of the improvements in the pills.

SEGMENTATION 

• 
• Request a Free sample to learn more about this report

• By Type

Based on type; the market is divided into levonorgestrel table, mixture products, hormone- releasing IUD

Levonorgestrel table type is the leading part of the type segment.

• By Application

Based on the application; the market is divided into hospital, drug store, online sale

Hospital is the leading part of the application segment.

DRIVING FACTORS

"Increasing Awareness Among People to Aid Market Expansion "

There are indeed biological and patented preparations of emergency pills obtainable, and the levonorgestrel market share is steadily increasing. According to the research results of this business journal, the distributors of this market are positioned for a prosperous future, with consumption increasing at a profitable rate over the forecast period as a result of rising increasing awareness in cosmopolitan areas around the world.

"Increasing Utilization During Menopause to Foster Industry Progress "

During menopause, the pill has always been combined with oestradiol as hormonal treatment to maintain vasomotor symptoms and avoid osteoporosis. It can be utilized to cure menorrhagia, endometrial hyperplasia, as well as endometriosis off-label.

RESTRAINING FACTORS

"Difficult and High Threat Procedures to Hinder Market Advancement"

This medication will still not prevent an ongoing childbirth or safeguard the person or the partner from sexually transmitted infections such as HIV (human immunodeficiency virus infection and acquired immune deficiency syndrome), gonorrhoea, and chlamydia. The above medicine might not even work well in women who are over a specific weight (for example, and over 164 kilos or 74 kilogrammes), or if one has recently utilised some other medications. This effect has the potential to result in pregnancy. During the anticipated period, the levonorgestrel market share is anticipated to be hindered by difficult prevention methods.

REGIONAL INSIGHTS 

• 
• Request a Free sample to learn more about this report

"Rising Living-In Relationships and Urban Culture to Foster Market Advancement in North America "

Among all regions, North America dominates the international levonorgestrel market. Numerous US-based organisations, including, that also aims to increase access to effective emergency contraception products, are expected to encourage the use of urgent situation pills between many people in this region. The rapid spread urban culture in emerging and developed markets in North America is demonstrating an increase in common agreement between many partners for unsafe intercourse, resulting in an increase in consumption for emergency pills.

KEY INDUSTRY PLAYERS

"Notable Players in the Industry to Promote Market Expansion "

The industry's growth was significantly influenced by the tactics employed by market participants in recent years, such as extensions. The report provides details and information on the companies and their interactions with the market. The data is gathered and published through appropriate research, technological advancements, expansions, and expanding machinery and equipment. Other criteria considered for this market are the firms that develop and provide new products, the areas in which they operate, mechanisation, innovative techniques, making the most money, and using their products to have a large social impact. This analysis examines the global and regional effects of the outbreak mostly on market. The study describes the market size features, and market growth by type, industry, and customer sector. Furthermore, it presents a complete examination of commercialization factors prior to and following the Covid-19 pandemic.

List of Market Players Profiled 

• Bayer (Germany)
• Paladin Labs (Canada)
• Foundation Consumer Healthcare (U.S.)
• Theramex (Teva) (London)
• Pfizer (U.S.)
• Apotex (Canada)
• HRA Pharma (France)

REPORT COVERAGE

The industry report examines the global market, geographic and country-level market sizes, categorization market expansion, market share, competitor analysis, sales trends, influence of domestic and international market players, supply chain enhancement, trade laws, latest developments, possibilities analysis, business strategy market expansion analysis, product releases, area competitive landscape expanding, and technological advancements.